Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SABR”

848 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 848 results

Not applicableEnded earlyNCT01976962
What this trial is testing

Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
CancerCare Manitoba 20
Not applicableUnknownNCT04351282
What this trial is testing

SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaMetastasisStereotactic Body Radiation Therapy
Fudan University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06130280
What this trial is testing

Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastases
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)UnknownNCT04913480
What this trial is testing

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 37
Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing

SAbR For Oligo-Progressive Renal Cell Cancer.

Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Not applicableUnknownNCT05807165
What this trial is testing

HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases

Who this might be right for
Brain Oligometastases
Chang Gung Memorial Hospital 115
Testing effectiveness (Phase 2)UnknownNCT06301828
What this trial is testing

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Who this might be right for
Gastrointestinal Neoplasms
Nanjing First Hospital, Nanjing Medical University 16
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT02298946
What this trial is testing

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT05616650
What this trial is testing

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Who this might be right for
Prostatic NeoplasmsProstate CancerProstate Adenocarcinoma
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07470840
What this trial is testing

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital 27
Testing effectiveness (Phase 2)UnknownNCT00727350
What this trial is testing

Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.

Who this might be right for
Non Small Cell Lung Carcinoma
Universitair Ziekenhuis Brussel 44
Not applicableStudy completedNCT01290835
What this trial is testing

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Essentia Health 20
Not applicableNot Yet RecruitingNCT06852001
What this trial is testing

Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

Who this might be right for
Brain MetastasisSRS
Tianjin Medical University Cancer Institute and Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Not applicableUnknownNCT02416609
What this trial is testing

Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Modena 44
Next Page